Patent · US Active

Stereospecific carbonyl reductases

US9422583B2 · kind B2 · utility

1Cited by
0References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 2, 2015
Grant dateAug 23, 2016
Priority date
Expiry dateMar 2, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Stereospecific carbonyl reductases SCR1, SCR2, and SCR3 are described herein as are nucleotide sequences that encode these reductases. These stereospecific carbonyl reductases have anti-Prelog selectivity and have specificities that are useful for fine biochemical synthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.